Bottom line
HLHIX vs IYH: the short answer
HLHIX (Virtus KAR Health Sciences Fund) and IYH (iShares U.S. Healthcare ETF) are both mutual funds.
But IYH is far broader, holding 103 positions to 24 for HLHIX, so beyond the top names it adds exposure HLHIX doesn't have.
IYH is cheaper at 0.37% vs 1.05% — a difference of $68 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +3.8% for HLHIX.
Updated Nov 19, 2026
HLHIX vs IYH side by side
| HLHIX | IYH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Virtus | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.05% | 0.37% |
| Annual cost per $10k | $105 | $37 |
| 10-yr cost on $10k (prospectus) | $1,367 | $468 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +7.6% | +13.1% |
| 5-yr return (annualized) | +3.8% | +7.0% |
| 10-yr return (annualized) | +7.1% | +9.4% |
| Best quarter | +16.5% | +15.3% |
| Worst quarter | −11.8% | −12.7% |
| Net assets (fund) | $91.7M | $3.6B |
| Number of holdings | 24 | 103 |
| Portfolio turnover | 13% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HLHIX | IYH | Difference |
|---|---|---|---|
| 2025 | +7.6% | +13.1% | −5.5% |
| 2024 | −2.0% | +3.1% | −5.1% |
| 2023 | +2.8% | +2.1% | +0.8% |
| 2022 | −11.6% | −4.4% | −7.2% |
| 2021 | +25.7% | +23.4% | +2.3% |
| 2020 | +14.1% | +15.5% | −1.4% |
Source: Fund prospectus bar charts
Holdings overlap
11 of HLHIX's top 24 holdings also appear in IYH's top 25.
| Holding | HLHIX | IYH |
|---|---|---|
| Eli Lilly & Company | 14.84% | 15.11% |
| Abbvie Inc | 5.52% | 7.32% |
| Vertex Pharmaceuticals Inc | 5.32% | 2.00% |
| Merck & Company Inc | 5.06% | 5.31% |
| Unitedhealth Group Inc | 4.65% | 6.16% |
| Intuitive Surgical Inc | 3.89% | 2.05% |
| Amgen Inc | 3.85% | 3.42% |
| Idexx Laboratories Inc | 3.77% | 0.73% |
| Thermo Fisher Scientific Inc | 3.65% | 3.52% |
| Danaher Corp | 3.37% | 2.03% |
| Regeneron Pharmaceuticals Inc | 2.90% | 1.27% |
Source: SEC Form N-PORT
HLHIX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between HLHIX and IYH?
Which is cheaper, HLHIX or IYH?
Should I own both HLHIX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.